Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

NCT00874796 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
307
Enrollment
INDUSTRY
Sponsor class

Stopped Reports of significant laboratory abnormalities and adverse events in a number of clinical study participants.

Conditions

Interventions

Sponsor

Gilead Sciences